key: cord-1027688-zgvhaqce
authors: Prasad, Shweta; Holla, Vikram Venkappayya; Neeraja, Koti; Surisetti, Bharath Kumar; Kamble, Nitish; Yadav, Ravi; Pal, Pramod Kumar
title: Parkinson's Disease and COVID‐19: Perceptions and Implications in Patients and Caregivers
date: 2020-05-08
journal: Mov Disord
DOI: 10.1002/mds.28088
sha: 9d00f45da33bac27847f022975f762bc288a7b13
doc_id: 1027688
cord_uid: zgvhaqce

nan

The COVID-19 pandemic has resulted in unprecedented disruptions involving every aspect of life across the globe, with the return to normalcy a distant dream. The healthcare sector has undergone dramatic changes to cope with the current needs, and consequently acute care is in the forefront. Attempts to curb COVID-19 have forced countries to be under lockdown, with strict emphases on self-isolation and social distancing. Both factors raise serious concerns about the well-being of patients with chronic illnesses such as Parkinson's disease (PD), as these patients require routine hospital visits for evaluation and dose adjustment. Currently, there is no evidence that patients with PD have a higher risk of contracting COVID-19 or have worse outcomes. [1] [2] [3] Although healthcare professionals may be aware of this, patients and their caregivers may harbor different perceptions pertaining to these interactions. Furthermore, lockdowns may restrict access to healthcare and physical exercise and may produce additional stress, which could potentially lead to the worsening of motor and nonmotor symptoms in this vulnerable group.

We report our experience at ascertaining the perceptions and implications of COVID-19 in 100 patients with PD and their caregivers who are under follow-up at the National Institute of Mental Health and Neurosciences, Bengaluru, India. Per the hospital directives, patients were contacted via telephone for routine follow-up, and questions pertaining to COVID-19 were asked to clarify misconceptions, if any ( Table 1 ). All participants reported an awareness of COVID-19, with television being the main source of information, and followed preventive measures. Most patients (82%) and caregivers (85%) did not attempt to explore interactions between COVID-19 and PD, as they felt that there was no association between them. However, a small percentage did not explore interactions as they "didn't know where to look." Perception of a higher risk of contracting COVID-19 was reported in 8% of patients and 4% of caregivers, and both groups implicated the possibility of a lower immunity secondary to PD and old age as risk factors. New problems attributed to the pandemic were reported by a few respondents and were associated with access to healthcare and medication. Finally, the worsening or new symptoms reported or perceived by patients (11%) and caregivers (10%) involved both motor and nonmotor symptoms. These results suggest that most patients and caregivers were well informed and coping well, and a very small proportion were harboring misconceptions with symptomatic worsening. However, our results may be influenced by the relatively lower severity of the pandemic in India, a lockdown that has been in place for barely 3 weeks, and better family support secondary to our sociocultural framework. Owing to this, the impact of the pandemic may not be completely reflected. Hence, these responses may vary between countries based on the severities of the pandemic and durations of the lockdowns. Misconceptions pertaining to PD and COVID-19 should be clarified by advisories catered toward patients and disseminated through sources that are population and location specific. The long-term consequences of this pandemic on PD is highly uncertain, and timely education and reassurance of patients may help ease the burden. Increased tremor 45.4% (5/11) 40% (4/10) Increased stiffness 18.1% (2/11) 0% (0/10) Increased slowness 0% (0/11) 20% (2/10) Excessive fatigue 18.1% (2/11) 0% (0/10) Feeling/appear stressed 9.0% (1/11) 0% (0/10) Feeling/appear depressed 9.0% (1/11) 30% (3/10) Reduced sleep 9.0% (1/11) 10% (1/10) Reduced appetite 0% (0/11) 10% (1/10) Increased aches and pains 9.0% (1/11) 20% (2/10) M, male; F, female; NA, not applicable.

The impact of the COVID-19 pandemic on Parkinson's disease: hidden sorrows and emerging opportunities

Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript: A. Writing of the First Draft, B. Review and Critique

1A, 1B, 1C